These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4388087)

  • 21. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 22. Route- and dose-dependent pharmacokinetics of hexobarbitone in the rat: a re-evaluation of the use of sleeping times in metabolic studies.
    Van der Graaff M; Vermeulen NP; Breimer DD
    J Pharm Pharmacol; 1985 Aug; 37(8):550-4. PubMed ID: 2864415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of prostaglandin E1 and disulfiram on the prolongation of hexobarbital hypnosis.
    Fukumori R; Minegishi A; Satoh T; Kitagawa H; Yanaura S
    Brain Res; 1980 Jan; 181(1):241-4. PubMed ID: 7350961
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolerance development to cadmium-induced alteration of drug action.
    Roberts SA; Miya TS; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):197-200. PubMed ID: 935651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 1,1,1-trichloroethane administered by different routes and in different solvents on barbiturate hypnosis and metabolism in mice.
    Shan HC; Lal H
    J Toxicol Environ Health; 1976 May; 1(5):807-16. PubMed ID: 1271486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA; Lubawy WC; Kostenbauder HB
    Life Sci; 1974 Apr; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract]   [Full Text] [Related]  

  • 27. Hexobarbital action in rats with flavonoid-deficiency.
    Endell W; Seidel G
    Experientia; 1976 Sep; 32(9):1189-90. PubMed ID: 971760
    [No Abstract]   [Full Text] [Related]  

  • 28. Sexual dimorphism and the effects of the X-linked Tfm locus on hexobarbitone metabolism and action in mice.
    King DK; Shapiro BH
    Br J Pharmacol; 1981 Sep; 74(1):97-104. PubMed ID: 7196788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of hexobarbital metabolism by diethylnitrosamine.
    Stevenson IH; Greenwood DT
    Biochem Pharmacol; 1968 May; 17(5):842-5. PubMed ID: 4297005
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction between manganese and phenobarbital on hexobarbital hypnosis in the male rat.
    Deimling MJ; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):165-8. PubMed ID: 6622829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of the relationship between aging and the duration of hexobarbital hypnosis in male CFN rats.
    Baird MB
    Exp Gerontol; 1983; 18(1):47-53. PubMed ID: 6873211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain and age variations in hexobarbital response.
    Catz C; Yaffe SJ
    J Pharmacol Exp Ther; 1967 Jan; 155(1):152-6. PubMed ID: 6066794
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors affecting the metabolism and response to hexobarbital.
    Furner RL; Gram TE; Stitzel RE
    Pharmacology; 1969; 2(3):181-9. PubMed ID: 5346144
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Symposium--drug metabolism and drug action. 6. Duration of sleep induced by hexobarbital following thyroidectomy hexobarbital metabolism].
    Tochino Y; Matsubarat ; Takase H
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):85-6. PubMed ID: 5531425
    [No Abstract]   [Full Text] [Related]  

  • 36. Further studies on the inhibition of drug metabolism by pregnanolone and related steroids.
    Soyka LF; Deckert FW
    Biochem Pharmacol; 1974 May; 23(11):1629-39. PubMed ID: 4367955
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of methylchloroform inhalation on barbiturate hypnosis and hepatic drug metabolism in male mice.
    Lal H; Shah HC
    Toxicol Appl Pharmacol; 1970 Nov; 17(3):625-33. PubMed ID: 5528147
    [No Abstract]   [Full Text] [Related]  

  • 38. Imipramine induced potentiation of hexobarbitone hypnosis in rat: role of serotonin.
    Bhattacharya SK
    Indian J Exp Biol; 1978 Mar; 16(3):362-3. PubMed ID: 680837
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract]   [Full Text] [Related]  

  • 40. Reticuloendothelial stimulation and drug metabolism.
    Barnes DW; Wooles WR
    J Reticuloendothel Soc; 1970 Jun; 7(6):684-94. PubMed ID: 4317319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.